human | Q5 |
P496 | ORCID iD | 0000-0001-5340-1500 |
P1053 | ResearcherID | E-6234-2018 |
P1153 | Scopus author ID | 20733909600 |
P734 | family name | Hermans | Q27254055 |
Hermans | Q27254055 | ||
Hermans | Q27254055 | ||
P735 | given name | Greet | Q21342555 |
Greet | Q21342555 | ||
P106 | occupation | researcher | Q1650915 |
P21 | sex or gender | female | Q6581072 |
Q46895738 | Acute intracardiac right-to-left shunt in a patient with acute respiratory distress syndrome and shock successfully treated with nitric oxide. |
Q34419891 | Acute outcomes and 1-year mortality of intensive care unit-acquired weakness. A cohort study and propensity-matched analysis |
Q43074167 | Alterations in adipose tissue during critical illness: An adaptive and protective response? |
Q38160666 | Assessment of limb muscle strength in critically ill patients: a systematic review |
Q57245084 | Assessment of quadriceps muscle mass with ultrasound in critically ill patients: intra- and inter-observer agreement and sensitivity |
Q37206684 | Benefits of intensive insulin therapy on neuromuscular complications in routine daily critical care practice: a retrospective study |
Q24649694 | Clinical review: Critical illness polyneuropathy and myopathy |
Q37521395 | Clinical review: Intensive insulin therapy in critically ill patients: NICE-SUGAR or Leuven blood glucose target? |
Q26799076 | Clinical review: intensive care unit acquired weakness |
Q33751235 | Critical illness induces nutrient-independent adipogenesis and accumulation of alternatively activated tissue macrophages |
Q51818904 | Early exercise in critically ill patients enhances short-term functional recovery. |
Q57245243 | Early versus Late Parenteral Nutrition in Critically Ill Adults |
Q46628244 | Effect of insulin therapy on coagulation and fibrinolysis in medical intensive care patients |
Q53070565 | Effect of tolerating macronutrient deficit on the development of intensive-care unit acquired weakness: a subanalysis of the EPaNIC trial. |
Q41658784 | Effects of controlled mechanical ventilation on sepsis-induced diaphragm dysfunction in rats |
Q57559938 | Endogenous Carbon Monoxide Production: A Rare and Detrimental Complication of Extracorporeal Membrane Oxygenation |
Q47370440 | Epidemiological characteristics, practice of ventilation, and clinical outcome in patients at risk of acute respiratory distress syndrome in intensive care units from 16 countries (PRoVENT): an international, multicentre, prospective study |
Q57559947 | Extracorporeal Membrane Oxygenation: Experience in an Adult Medical ICU |
Q50646686 | Feasibility of neuromuscular electrical stimulation in critically ill patients. |
Q92864497 | Five-year impact of ICU-acquired neuromuscular complications: a prospective, observational study |
Q93086480 | Five-year mortality and morbidity impact of prolonged versus brief ICU stay: a propensity score matched cohort study |
Q57559940 | Galactomannan in Bronchoalveolar Lavage Fluid |
Q44508523 | Greater diaphragm fatigability in individuals with recurrent low back pain |
Q38041037 | ICU-based rehabilitation and its appropriate metrics |
Q34552719 | Impact of early parenteral nutrition completing enteral nutrition in adult critically ill patients (EPaNIC trial): a study protocol and statistical analysis plan for a randomized controlled trial. |
Q36880413 | Impact of early parenteral nutrition on metabolism and kidney injury |
Q34586285 | Impact of intensive insulin therapy on neuromuscular complications and ventilator dependency in the medical intensive care unit |
Q41771779 | Increased duration of mechanical ventilation is associated with decreased diaphragmatic force: a prospective observational study |
Q100309393 | Intensive care unit acquired muscle weakness in COVID-19 patients |
Q47976182 | Intensive care unit-acquired weakness |
Q34490623 | Intensive insulin therapy in the medical ICU. |
Q57245228 | Interobserver agreement of medical research council sum-score and handgrip strength in the intensive care unit |
Q24200934 | Interventions for preventing critical illness polyneuropathy and critical illness myopathy |
Q24241368 | Interventions for preventing critical illness polyneuropathy and critical illness myopathy |
Q24243431 | Interventions for preventing critical illness polyneuropathy and critical illness myopathy |
Q46793359 | Invasive pulmonary aspergillosis in the ICU: reply to Wichmann et al. |
Q43631437 | Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study |
Q42244078 | Lectin pathway of complement activation and relation with clinical complications in critically ill children |
Q37666366 | Metabolic aspects of critical illness polyneuromyopathy |
Q51007787 | Muscle atrophy and preferential loss of myosin in prolonged critically ill patients. |
Q38462086 | Neurocognitive development of children 4 years after critical illness and treatment with tight glucose control: a randomized controlled trial |
Q46121568 | Pharmacokinetics of caspofungin and voriconazole in critically ill patients during extracorporeal membrane oxygenation |
Q41489882 | Predictive value for weakness and 1-year mortality of screening electrophysiology tests in the ICU. |
Q37667505 | Premorbid obesity, but not nutrition, prevents critical illness-induced muscle wasting and weakness. |
Q26741099 | Prolonged Glucocorticoid Treatment in ARDS: Impact on Intensive Care Unit-Acquired Weakness |
Q53116971 | Recurrent high gastrointestinal bleeds after Belsey Mark IV antireflux procedure. |
Q42620035 | Relationship between Abdominal Pressure, Pulmonary Compliance, and Cardiac Preload in a Porcine Model |
Q57245233 | Reply |
Q57245212 | Role of Disease and Macronutrient Dose in the Randomized Controlled EPaNIC Trial |
Q35559316 | Should we abandon manual muscle strength testing in the ICU? |
Q49113819 | Targeted temperature management and neuroprognostication after cardiac arrest: A survey in Belgium |
Q38495305 | The Molecular Adsorbent Recirculating System in patients with severe liver failure: clinical results at the K.U. Leuven |
Q34483183 | The Sick and the Weak: Neuropathies/Myopathies in the Critically Ill. |
Q38070220 | The assessment of inspiratory muscle fatigue in healthy individuals: a systematic review |
Q50471445 | The influence of continuous venovenous renal replacement therapy on the plasma disappearance rate of indocyanine green. |
Q39750085 | The interobserver agreement of handheld dynamometry for muscle strength assessment in critically ill patients |
Q90761648 | The urea-creatinine ratio as a novel biomarker of critical illness-associated catabolism |
Q57245299 | Tight Glucose Control in Critically Ill Adults |
Q46420959 | Usefulness of FDG-PET to diagnose intravascular lymphoma with encephalopathy and renal involvement |
Q100513286 | Weakness in the ICU: the right weight on the right scale |
Q57559950 | pH 48 h After Onset of Extracorporeal Membrane Oxygenation Is an Independent Predictor of Survival in Patients With Respiratory Failure |